U.S. Supreme Court Rejects Appeal Over Patents for Off-Market Uses of Drugs

Law360 (December 1, 2003, 12:00 AM EST) -- In a setback for research-based drugmakers, the U.S. Supreme Court declined to hear an appeal over patent rights for drugs prescribed for off-market uses.

Allergan had appealed to the Supreme Court to bar a unit of pharmaceutical companies Alcon and Bausch & Lomb from manufacturing brimonidine. The case is Allergan v. Alcon and Bausch & Lomb, 03-443.

Brimonidine is used as a drug therapy for open-angle glaucoma, an eye disease that can lead to blindness, but can also be effective in preventing the death of optic...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.